Name Dose Classification Indication Contraindication Side Effects Nursing

Responsibili
ties
Ranitidi  Treatment  Anti-ulcer  Inhibits the  Hypersensitivit  CNS: • Assess
ne of agents action of y, Cross- Confusion, patient for
heartburn,  Histamine- histamine at sensitivity may dizziness, epigastric or
Zantac acid 2 (H2) the H2 occur; some drowsiness, abdominal
indigestion: antagonist receptor site oral liquids hallucinations, pain and
75 mg PO as located contain alcohol headache frank or
needed. primarily in and should be  CV: occult blood
 Maintenanc gastric avoided in Arrhythmias in the stool,
e therapy, parietal patients with  GI: Altered emesis, or
duodena/ga cells, known taste, black gastric
stric l ulcer: resulting in intolerance tongue, aspirate.
150mg PO at inhibition of  Renal constipation, • Nurse
bedtime gastric acid impairment dark stools, should know
secretion  Pregnancy or diarrhea, drug- that it may
 Short-term lactation induced cause false-
treatment of hepatitis, positive
active nausea results for
duodenal  GU: urine
ulcer Decreased protein; test
 Maintenanc sperm count, with
e therapy impotence sulfosalicylic
for duodenal  HEMATOLOGI acid.
ulcer at C: • Inform
reduced Agranulocytosi patient that
dosage s, Aplastic it may cause
 Treatment Anemia, drowsiness
of neutropenia, or dizziness.
heartburn, thrombocytop • Inform
acid enia patient that
indigestion, increased
sour fluid and
stomach fiber intake
may
minimize
constipation.
• Advise
patient to
report onset
of black,
tarry stools;
fever, sore
throat;
diarrhea;
dizziness;
rash;
confusion; or
hallucination
s to health
care
professional
promptly.
• Inform
patient that
medication
may
temporarily
cause stools
and tongue
to appear
gray black.